Roche's RoACTEMRA approved in Europe for children living with a rare and ... - PipelineReview.com (press release)

Roche's RoACTEMRA approved in Europe for children living with a rare and ... PipelineReview.com (press release) sJIA is the rarest form of Juvenile Idiopathic Arthritis (JIA), also known as Juvenile Rheumatoid Arthritis (JRA).(1) The disease affects about 10 to 20 percent of children with JIA,(2) with the peak age of onset between 18 months and two years,(2,3) ... and more »

Tocizilumab: Arthritis drug allows bedridden children to return to normal life - Daily Mail

Daily Mail

Tocizilumab: Arthritis drug allows bedridden children to return to normal life Daily Mail Professor Patricia Woo, professor of paediatric rheumatology at London's Great Ormond Street Hospital, which also took part in the trial, said 'Systemic juvenile arthritis can be a devastating disease. 'It strikes often very young children, ... Arthritis drug offers children hopeThe Independent all 50 news articles »

Doing all she can - Foxboro Reporter

Doing all she can Foxboro Reporter The pain began when Gibbons was just 4 years old, but it wasn't until she was 6 that she was diagnosed with juvenile rheumatoid arthritis. "It was scary," Lindsay's mother, Allison Gibbons, said. "We didn't know for two years, and then were given a ...

Roche gets RoActemra Europe OK for children with RA - Pharma Times

Roche gets RoActemra Europe OK for children with RA Pharma Times sJIA is the rarest form of juvenile rheumatoid arthritis which has a 2%-4% mortality rate, and accounts for almost two-thirds of all deaths among children with arthritis. It can include symptoms ranging from joint inflammation accompanied by ... and more »